866-997-4948(US-Canada Toll Free)

Sickle Cell Disease Global Clinical Trials Review, H2, 2018

Published By :

GlobalData

Published Date : Jul 2018

Category :

Pharmaceutical

No. of Pages : 296 Pages

Sickle Cell Disease Global Clinical Trials Review, H2, 2018

Summary

GlobalData's clinical trial report, Sickle Cell Disease Global Clinical Trials Review, H2, 2018" provides an overview of Sickle Cell Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Sickle Cell Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalDatas proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Sickle Cell Disease to Hematological Disorders Clinical Trials 16
Clinical Trials by Phase in G7 Countries 18
Clinical Trials in G7 Countries by Trial Status 19
Clinical Trials by E7 Countries: Proportion of Sickle Cell Disease to Hematological Disorders Clinical Trials 21
Clinical Trials by Phase in E7 Countries 23
Clinical Trials in E7 Countries by Trial Status 24
Clinical Trials by Phase 25
In Progress Trials by Phase 26
Clinical Trials by Trial Status 27
Clinical Trials by End Point Status 29
Subjects Recruited Over a Period of Time 30
Clinical Trials by Sponsor Type 31
Prominent Sponsors 32
Top Companies Participating in Sickle Cell Disease Therapeutics Clinical Trials 34
Prominent Drugs 36
Latest Clinical Trials News on Sickle Cell Disease 37
Jul 18, 2018: Emmaus Life Sciences Announces the New England Journal of Medicine has Published the Phase 3 Trial Results of Endari (L-Glutamine Oral Powder) in Sickle Cell Disease 37
Jun 27, 2018: GBT Announces Positive Top-line Data from Part A of the Phase 3 HOPE Study of Voxelotor in Sickle Cell Disease 37
Jun 15, 2018: GBT Announces New Phase 2a Voxelotor Data in Adolescents with Sickle Cell Disease (SCD) at 23rd European Hematology Association (EHA) Congress 38
Jun 15, 2018: bluebird bio Announces New Interim Data from Phase 1 (HGB-206) Study of LentiGlobin Gene Therapy in Patients with Severe Sickle Cell Disease at Annual Congress of the European Hematology Association 38
Jun 08, 2018: GBT Announces Upcoming Data Presentations Supporting Voxelotor Sickle Cell Disease Program at Foundation for Sickle Cell Disease Researchs 12th Annual Symposium 39
May 21, 2018: MaxCyte Reports Preclinical Results at ASGCT Annual Meeting Showing Correction of Sickle Cell Disease Mutation in Hematopoietic Stem Cells 40
May 17, 2018: bluebird bio to Present New Data from LentiGlobin Transfusion-Dependent -Thalassemia and Severe Sickle Cell Disease Clinical Studies at Annual Congress of the European Hematology Association 40
May 17, 2018: GBT Announces Upcoming Data Presentations Supporting Voxelotor Sickle Cell Disease Program at 23rd European Hematology Association (EHA) Congress 40
Clinical Trial Profile Snapshots 42
Appendix 294
Abbreviations 294
Definitions 294
Research Methodology 295
Secondary Research 295
About GlobalData 296
Contact Us 296
Disclaimer 296
Source 296

List of Tables
Sickle Cell Disease Therapeutics, Global, Clinical Trials by Region, 2018* 7
Sickle Cell Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9
Sickle Cell Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Sickle Cell Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 11
Sickle Cell Disease Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 12
Sickle Cell Disease Therapeutics Clinical Trials, North America, Top Countries, 2018* 13
Sickle Cell Disease Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2018* 14
Sickle Cell Disease Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2018* 15
Proportion of Sickle Cell Disease to Hematological Disorders Clinical Trials, G7 Countries (%), 2018* 17
Sickle Cell Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 18
Sickle Cell Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 20
Proportion of Sickle Cell Disease to Hematological Disorders Clinical Trials, E7 Countries (%), 2018* 22
Sickle Cell Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 23
Sickle Cell Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 24
Sickle Cell Disease Therapeutics, Global, Clinical Trials by Phase, 2018* 25
Sickle Cell Disease Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 26
Sickle Cell Disease Therapeutics, Global, Clinical Trials by Trial Status, 2018* 28
Sickle Cell Disease Therapeutics Clinical Trials, Global, by End Point Status, 2018* 29
Sickle Cell Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 30
Sickle Cell Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 31
Sickle Cell Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 33
Sickle Cell Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 35
Sickle Cell Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 36

List of Figures
Sickle Cell Disease Therapeutics, Global, Clinical Trials by Region (%), 2018* 7
Sickle Cell Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
Sickle Cell Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Sickle Cell Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 11
Sickle Cell Disease Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 12
Sickle Cell Disease Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 13
Sickle Cell Disease Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2018* 14
Sickle Cell Disease Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2018* 15
Proportion of Sickle Cell Disease to Hematological Disorders Clinical Trials, G7 Countries (%), 2018* 16
Sickle Cell Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 18
Sickle Cell Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 19
Proportion of Sickle Cell Disease to Hematological Disorders Clinical Trials, E7 Countries (%), 2018* 21
Sickle Cell Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 23
Sickle Cell Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 24
Sickle Cell Disease Therapeutics, Global, Clinical Trials by Phase (%), 2018* 25
Sickle Cell Disease Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 26
Sickle Cell Disease Therapeutics, Global, Clinical Trials by Trial Status, 2018* 27
Sickle Cell Disease Therapeutics Clinical Trials, Global, by End Point Status, 2018* 29
Sickle Cell Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 30
Sickle Cell Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 31
Sickle Cell Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 32
Sickle Cell Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 34
Sickle Cell Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 36
GlobalData Methodology 295

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *